Abstract
Tuberculosis is a major global health problem: the World Health Organisation estimates that there were 9.4 million incident cases and 1.8 million deaths from the disease in 2008. The development of new agents to prevent acquisition or reactivation of latent Mycobacterium tuberculosis infection and to allow shortening of antimicrobial therapy regimens for active tuberculosis without loss of efficacy is a research priority. In this article we describe the immunomodulatory actions of vitamin D metabolites in mycobacterial infection and review the growing body of evidence from observational and intervention studies suggesting that vitamin D might have a role in the prevention and treatment of TB.
Keywords: Tuberculosis, vitamin D, immunomodulation, clinical trials, Mycobacterium tuberculosis, Human Immunodeficiency Virus, macrophage, anti-tuberculous chemotherapy, vitamin D binding protein (DBP), polymorphism
Current Respiratory Medicine Reviews
Title: Vitamin D and Tuberculosis
Volume: 7 Issue: 6
Author(s): Kirsten Mitchell, Christopher J. Griffiths and Adrian R. Martineau
Affiliation:
Keywords: Tuberculosis, vitamin D, immunomodulation, clinical trials, Mycobacterium tuberculosis, Human Immunodeficiency Virus, macrophage, anti-tuberculous chemotherapy, vitamin D binding protein (DBP), polymorphism
Abstract: Tuberculosis is a major global health problem: the World Health Organisation estimates that there were 9.4 million incident cases and 1.8 million deaths from the disease in 2008. The development of new agents to prevent acquisition or reactivation of latent Mycobacterium tuberculosis infection and to allow shortening of antimicrobial therapy regimens for active tuberculosis without loss of efficacy is a research priority. In this article we describe the immunomodulatory actions of vitamin D metabolites in mycobacterial infection and review the growing body of evidence from observational and intervention studies suggesting that vitamin D might have a role in the prevention and treatment of TB.
Export Options
About this article
Cite this article as:
Mitchell Kirsten, J. Griffiths Christopher and R. Martineau Adrian, Vitamin D and Tuberculosis, Current Respiratory Medicine Reviews 2011; 7 (6) . https://dx.doi.org/10.2174/157339811798072685
DOI https://dx.doi.org/10.2174/157339811798072685 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Aminoglycoside Antibiotics Effective Against Resistant Bacterial Strains
Current Topics in Medicinal Chemistry The Coronin Family and Human Disease
Current Protein & Peptide Science Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Synthetic Polyacrylate Polymers as Particulate Intranasal Vaccine Delivery Systems for the Induction of Mucosal Immune Response
Current Drug Delivery Ischemic Colitis: Current Diagnosis and Treatment
Current Drug Targets A Review on Nuclear Imaging as a Promising Modality for Efficient Diagnosis of Tuberculosis
Current Medical Imaging Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection
Current Immunology Reviews (Discontinued) Novel Thiazole Carboxylic Acid Derivatives Possessing a “Zinc Binding Feature” as Potential Human Glyoxalase-I Inhibitors
Letters in Drug Design & Discovery Recent Patents for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Antibiotic Use in Children - Off-Label Use
Current Drug Targets Synthesis, Docking and Antidiabetic Activity of Some Newer Benzamide Derivatives as Potential Glucokinase Activators
Letters in Drug Design & Discovery Editorial [Hot Topic: Nucleoside and Nucleotide Therapeutics: Recent Targets in Medicinal Chemistry (Guest Editor: Claire Simons)]
Current Topics in Medicinal Chemistry Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis
Current Drug Delivery Toll-Like Receptors: Role in Inflammation and Commensal Bacteria
Inflammation & Allergy - Drug Targets (Discontinued) Chronic Stress and Diabetes Mellitus: Interwoven Pathologies
Current Diabetes Reviews Preface
Current Drug Targets - Infectious Disorders An Update on Natural Products with Carbonic Anhydrase Inhibitory Activity
Current Pharmaceutical Design Adjunctive Immunotherapeutic Efficacy of N-Formylated Internal Peptide of Mycobacterial Glutamine Synthetase in Mouse Model of Tuberculosis
Protein & Peptide Letters In vitro and In silico Analysis of β-lactam Derivatives as Antimycobacterial Agents
Letters in Drug Design & Discovery